Global Medical Technology Industry Dynamics, Insights, and Announcements
Beyeonics Surgical and Beyeonics Vision are medical technology companies that aim to interface the systems in operating rooms using augmented reality, tracking and image processing/AI platforms
Read More
the fund to be used for continuing the development of its therapies for obstructive sleep apnea (OSA)
Read More
Francis Medical plans to use the Series B proceeds to fund the development of its proprietary prostate cancer treatment through FDA 510(k) approval, which includes a pivotal clinical study (VAPOR 2) for the management of prostate cancer, scheduled to begin enrollment in August 2022
Read More
Proceeds from new investors will fund in vivo and clinical development of innovative platform for aneurysmal disease, including Abdominal Aortic Aneurysms (AAA)
Read More
Zhejiang Shuwen Biotechnology Co., Ltd. recently announced the completion of round B financing of nearly 100 million yuan led by Guolian Investment, followed by Shuncheng Capital, Anyuan Fund,
Read More
Funding to further advance Locate Bio’s regenerative medicine pipeline of orthobiologics
Read More
Meizhong Jiahe focuses on the development and management of comprehensive cancer hospitals and standalone radiotherapy and diagnostic imaging centers in China
Read More
new funding will accelerate Ultromics’ use of AI-enabled echocardiograms to improve patient outcomes
Read More
Funds will allow Medcura to expand its commercial footprint and support IDE submission for a new class of surgical hemostat
Read More
GWave 2.0 delivers accurate, affordable, and accessible continuous monitoring and testing for blood glucose, improving the quality of life for the global diabetes population
Read More